✦ LIBER ✦

Recombinant activated factor VII in the treatment of non-haemophilia patients: physician under-reporting of thromboembolic adverse events

✍ Scribed by C. C. Hsia; J. H. Zurawska; M. Z. Y. Tong; K. Eckert; V. C. McAlister; I. H. Chin-Yee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High Incidence of Thromboembolic Events

✍ Brian A. Bruckner; Daniel J. DiBardino; Qian Ning; Alfred Adeboygeun; Karim Mahm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The effects of recombinant activated fac

✍ Bucklin, Mason H.; Acquisto, Nicole M.; Nelson, Catherine 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 175 KB

The effect of recombinant activated fact

✍ L. Phillips; D. Dinh; B. Billah; C. Reid; P. Cameron 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Efficacy of different doses of recombina

✍ A. CHUANSUMRIT; N. SIRACHAINAN; S. PAKAKASAMA; A. SUEBSANGAD; S. CHOTSUPPAKARN; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

PSY27 THE LONG-TERM COST OF ORTHOPAEDIC

✍ Å Ericsson; M Haglund 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

On-demand treatment of bleeds in haemoph

✍ B. SØRENSEN; Y. DARGAUD; G. KENET; J. LUSHER; A. MUMFORD; S. PIPE; A. TIEDE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB